Table 3.
Multivariable Cox regression analysis for predicting cardiovascular adverse events.
Variables | Univariable | Multivariable | ||||
---|---|---|---|---|---|---|
HR | 95% CI | P value | HR | 95% CI | P value | |
Male | 0.899 | 0.495–1.633 | 0.727 | |||
Age | 0.983 | 0.949–1.018 | 0.339 | |||
Hypertension | 2.831 | 1.318–6.080 | 0.008∗∗ | 2.435 | 1.130–5.248 | 0.023∗ |
Diabetes mellitus | 1.403 | 0.695–2.833 | 0.345 | |||
Smoking | 0.654 | 0.360–1.187 | 0.162 | |||
LVEF | 0.954 | 0.914–0.996 | 0.033∗ | 0.956 | 0.914–1.000 | 0.048∗ |
CK-MB | 0.996 | 0.980–1.011 | 0.591 | |||
Creatinine | 1.010 | 0.979–1.042 | 0.537 | |||
LDL-c | 0.049 | 0.000–1387212.1 | 0.762 | |||
PCI | 0.619 | 0.345–1.110 | 0.107 | |||
Gensini score | 1.006 | 1.002–1.009 | 0.001∗∗ | 1.006 | 1.002–1.009 | 0.002∗∗ |
Low VEGF | 0.522 | 0.284–0.962 | 0.037∗ | 0.531 | 0.286–0.985 | 0.048∗ |
Variables were brought into multivariable analysis (P < 0.1). HR: hazard ratio; CI: confidence interval. ∗P < 0.05; ∗∗P < 0.01. LVEF: left ventricular ejection fraction; CK-MB: creatine kinase-MB; LDL-c: low-density lipoprotein cholesterol; PCI: percutaneous coronary intervention; VEGF: vascular endothelial growth factor.